Always deliver more than expected.
0
+
Successful Projects
$ 0
M +
Cumulative Funding
0
Regional Offices
0
k +
Professional Team
Our Research
Quality Research
DNDI
The Living study 2018-19 is a multi-country study - across Tanzania, Kenya and Uganda - funded by the Drugs for Neglected Diseases Initiative (DNDI), which aims at evaluating the effectiveness of Lopinavir/ritonavir (LPV/r) pellets, in addition to other NRTIs, in pediatric ART in routine care settings, among children.....
PPIUD
PPIUD is a family planning implementation research project funded by International Federation of the Gynecologists and obstetricians (FIGO) and implemented by the Association of Gynecologist and Obstetrician in Tanzania (AGOTA), Harvard T.H. Chan School of Public Health (HSPH) and MDH.
UZAZI BORA
Uzazi Bora was a two-year implementation research project implemented by MDH in collaboration with Temeke MMOH, the Tanzania Ministry of Health, and the Harvard T.H. Chan School of Public Health and the François-Xavier Bagnoud Center for Health and Human Rights (FXB) at Harvard University.The overall aim of the project was to....
Cash Transfer
The Afya II is randomized comparative controlled trial - funded by the University of California Berkeley - implemented by MDH in collaboration with Health for a Prosperous Nation (HPON-TZ) in Shinyanga, Tanzania. The study aims at optimizing the efficiency and implementation of cash transfers to improve ART adherence among PLHIVs.
TVO4 & TVO5
TOV4 and TOV5 studies are two separate individual-randomized, double-blinded, placebo-controlled clinical trials of vitamin D, part of a long series of vitamin clinical trials among PLHIVs that MDH has been conducting in partnership with the Harvard T.H. Chan School of Public Health (HSPH) and Muhimbili University of Health and Allied Sciences (MUHAS).
Our Skills
Through gaining experience in various sectors we have achieve to prevent the spread of HIV, Covid and TB in Four regions Tabora, Geita, Kagera and Dar es salaam in the following percentage.
HIV
0%
COVID
0%
TB
0%